64 related articles for article (PubMed ID: 38673808)
1. Plasma cfDNA abundance as a prognostic biomarker for higher risk of death in geriatric cardiovascular patients.
Cardelli M; Marchegiani F; Stripoli P; Piacenza F; Recchioni R; Di Rosa M; Giacconi R; Malavolta M; Galeazzi R; Arosio B; Cafarelli F; Spannella F; Cherubini A; Lattanzio F; Olivieri F
Mech Ageing Dev; 2024 Jun; 219():111934. PubMed ID: 38604436
[TBL] [Abstract][Full Text] [Related]
2. Circulating cell-free DNA does not harbour a diagnostic benefit in cats with feline diffuse iris melanomas.
Rushton JG; Ertl R; Klein D; Tichy A; Nell B
J Feline Med Surg; 2019 Feb; 21(2):124-132. PubMed ID: 29529957
[TBL] [Abstract][Full Text] [Related]
3. Isolation and Characterization of Cell-Free DNA from Cerebral Organoids.
Silver BB; Brooks A; Gerrish K; Tokar EJ
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791569
[TBL] [Abstract][Full Text] [Related]
4. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A
Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958
[TBL] [Abstract][Full Text] [Related]
5. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.
Thuy MN; Kam JK; Lee GC; Tao PL; Ling DQ; Cheng M; Goh SK; Papachristos AJ; Shukla L; Wall KL; Smoll NR; Jones JJ; Gikenye N; Soh B; Moffat B; Johnson N; Drummond KJ
J Clin Neurosci; 2015 May; 22(5):785-99. PubMed ID: 25698544
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
Kefayat A; Amouheidari A; Ghahremani F; Alirezaei Z
Cancer Med; 2021 Aug; 10(15):5154-5162. PubMed ID: 34250760
[TBL] [Abstract][Full Text] [Related]
8. Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.
Bagley SJ; Nabavizadeh SA; Mays JJ; Till JE; Ware JB; Levy S; Sarchiapone W; Hussain J; Prior T; Guiry S; Christensen T; Yee SS; Nasrallah MP; Morrissette JJD; Binder ZA; O'Rourke DM; Cucchiara AJ; Brem S; Desai AS; Carpenter EL
Clin Cancer Res; 2020 Jan; 26(2):397-407. PubMed ID: 31666247
[TBL] [Abstract][Full Text] [Related]
9. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients.
Valpione S; Gremel G; Mundra P; Middlehurst P; Galvani E; Girotti MR; Lee RJ; Garner G; Dhomen N; Lorigan PC; Marais R
Eur J Cancer; 2018 Jan; 88():1-9. PubMed ID: 29175734
[TBL] [Abstract][Full Text] [Related]
10. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
[TBL] [Abstract][Full Text] [Related]
11. Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis.
Palande V; Siegal T; Detroja R; Gorohovski A; Glass R; Flueh C; Kanner AA; Laviv Y; Har-Nof S; Levy-Barda A; Viviana Karpuj M; Kurtz M; Perez S; Raviv Shay D; Frenkel-Morgenstern M
Mol Oncol; 2022 May; 16(10):2098-2114. PubMed ID: 34875133
[TBL] [Abstract][Full Text] [Related]
12. Cytokine Profile in Development of Glioblastoma in Relation to Healthy Individuals.
Jarmuzek P; Defort P; Kot M; Wawrzyniak-Gramacka E; Morawin B; Zembron-Lacny A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003396
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis.
Jarmuzek P; Kozlowska K; Defort P; Kot M; Zembron-Lacny A
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444448
[TBL] [Abstract][Full Text] [Related]
14. Circulating DNA fragmentomics and cancer screening.
Thierry AR
Cell Genom; 2023 Jan; 3(1):100242. PubMed ID: 36777187
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Cell-Free DNA Size Distribution in Osteosarcoma Patients.
Udomruk S; Phanphaisarn A; Kanthawang T; Sangphukieo A; Sutthitthasakul S; Tongjai S; Teeyakasem P; Thongkumkoon P; Orrapin S; Moonmuang S; Klangjorhor J; Pasena A; Suksakit P; Dissook S; Puranachot P; Settakorn J; Pusadee T; Pruksakorn D; Chaiyawat P
Clin Cancer Res; 2023 Jun; 29(11):2085-2094. PubMed ID: 36735493
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
